Clinical Trials Sponsored by Barretos Cancer Hospital

Total 9797 results

Fujian Cancer Hospital

Enrolling by invitation

Tislelizumab as Cross-line Treatment for Advanced NSCLC

Advanced Non-small-cell Lung Cancer

China
Fujian Cancer Hospital

Withdrawn

Study of FMT Combined With Nivolumab in Gastric Cancer

Gastric Adenocarcinoma | Esophagus Adenocarcinoma | Esophagogastric Junction Adenocarcinoma

China
Fujian Cancer Hospital

Unknown

Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital

Completed

POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC

Malignant Neoplasm of Stomach Stage IV

China
Fujian Cancer Hospital

Withdrawn

Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

China
Fujian Cancer Hospital

Completed

Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

Cancer Pain

China
Fujian Cancer Hospital

Completed

To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Completed

Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer

Breast Cancer | HER2 | Preoperative Systemic Treatment
Zhejiang Cancer Hospital

Unknown

TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)

Carcinoma, Hepatocellular
Fujian Cancer Hospital

Unknown

Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain

Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive
Henan Cancer Hospital

Completed

Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

Esophageal Cancer

China
Zhejiang Cancer Hospital

Unknown

Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Nasopharyngeal Carcinoma

China
Henan Cancer Hospital

Unknown

the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Chemotherapy-induced Nausea and Vomiting | Tumor

China
Henan Cancer Hospital

Unknown

Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer

Small Cell Lung Cancer | Chemotherapy | Adoptive Cellular Immunotherapy | Maintenance | Extensive Disease

China
Henan Cancer Hospital

Unknown

The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province

Gastric Cancer

China
Henan Cancer Hospital

Unknown

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B-cell Lymphoma

China
Fujian Cancer Hospital

Unknown

PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer

Advanced Gastric Adenocarcinoma

China
Zhejiang Cancer Hospital

Unknown

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Cervical Cancer

China
Fujian Cancer Hospital

Unknown

Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy Regimens (ASGARD)

Advanced Metastatic Gastric Cancer
Zhejiang Cancer Hospital

Unknown

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

Peripheral T Cell Lymphoma

China
Zhejiang Cancer Hospital

Unknown

Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

Breast Cancer | Breast Diseases | Neoplasm, Breast

China
Henan Cancer Hospital

Unknown

Treatment of Advanced Gastrointestinal Tumors With Albumin Taxol

Advanced Gastrointestinal Tumors

China
Zhejiang Cancer Hospital

Unknown

Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer

Rectal Neoplasms | Neoadjuvant Therapy | Circulating Tumor DNA

China
Zhejiang Cancer Hospital

Unknown

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Breast Cancer

China
Fujian Cancer Hospital

Completed

Effects of Anesthesia on Tumor Immunity and Insulin Resistance During Perioperative Period

Cervical Cancer | Anesthesia | Carbohydrate | Tumor Immunity

China
Zhejiang Cancer Hospital

Unknown

The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer (PECP)

Breast Cancer | Breast Neoplasms | Breast Diseases
Zhejiang Cancer Hospital

Unknown

The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer
Zhejiang Cancer Hospital

Completed

Remifemin Preventing the Climacteric Symptoms in Breast Cancer

Safety Issues | Effect of Drugs

China
Fujian Cancer Hospital

Unknown

Next-generation Sequencing in Gastrointestinal Cancer

Gastrointestinal Cancer

China
Hangzhou Cancer Hospital

Unknown

SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Esophageal Cancer | Stereotactic Body Radiation Therapy | Metastatic Esophageal Cancer | Thymalfasin

China
Zhejiang Cancer Hospital

Unknown

Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis

Cerebral Radiation Necrosis

China
Zhejiang Cancer Hospital

Unknown

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital

Unknown

mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction

China
Ningbo Cancer Hospital

Unknown

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

Chemotherapy | Advanced Lung Cancer | Precision Cell Immunotherapy

China
Ningbo Cancer Hospital

Unknown

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Advanced Liver Cancer | Precision Cell Immunotherapy | Transcatheter Arterial Chemoembolization

China
Zhejiang Cancer Hospital

Unknown

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme

China
Theagenio Cancer Hospital

Completed

Fast Track Rehabilitation Following Video-assisted Lung Segmentectomy

Multiple Pulmonary Nodules

Greece
Zhejiang Cancer Hospital

Unknown

D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer

Gastric Cancer

China
Zhejiang Cancer Hospital

Unknown

Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer

Drug Safety | Surgically-Created Resection Cavity

China
Zhejiang Cancer Hospital

Completed

S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer

Esophageal Cancer

China
Zhejiang Cancer Hospital

Completed

S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer

Esophageal Cancer

China
Zhejiang Cancer Hospital

Completed

Zoladex Plus Tamoxifen in Breast Cancer

Ultrasonography | Lipemia | Endometrium | Mammography | Estrogen

China
Zhejiang Cancer Hospital

Unknown

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

Non-small Cell Lung Cancer

China
Taizhou Hospital
Taizhou Enze Medical Center (Group) Enze Hospital; Taizhou Cancer Hospital

Recruiting

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Henan Cancer Hospital

Not yet recruiting

This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma

Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell
Zhejiang Cancer Hospital

Not yet recruiting

Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma

Esophageal Cancer | Elderly Patients | Immunotherapy | Sintilimab | Chemoradiotherapy
Henan Cancer Hospital

Recruiting

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Extensive Small Cell Lung Cancer

China
Hunan Cancer Hospital

Recruiting

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Hubei Cancer Hospital

Not yet recruiting

SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

Breast Cancer

3

Subscribe